ABCL - AbCellera Biologics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ABCL is currently covered by 4 analysts with an average potential upside of $19.09 (167.35%) backed by displayed 7 price targets and 19 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5% with an average time for these price targets to be met of 46.75 days.

Highest price target for ABCL is 16, Lowest price target is 6, average price target is 11.

Most recent stock forecast was given by TIAGO FAUTH from CREDIT SUISSE on 22-Feb-2023. First documented stock forecast 25-Jan-2021.

Best performing analysts who are covering ABCL - AbCellera Biologics:

Do Kim Puneet Souda Tiago Fauth Gary Nachman

Currently, out of the existing stock ratings of ABCL - 14 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

34

$28.92 (569.29%)

34

6 months 30 days ago

0/4 (0%)

$24.05 (212.56%)

Buy

32

$26.92 (529.92%)

50

6 months 30 days ago

0/2 (0%)

$26.28 (203.09%)

Buy

21

$15.92 (313.39%)

22

8 months 1 days ago

0/7 (0%)

$15.17 (154.55%)

Buy

18

$12.92 (254.33%)

20

8 months 15 days ago

1/5 (20%)

$10.87 (99.20%)

187

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABCL (AbCellera Biologics) average time for price targets to be met?

On average it took 46.75 days on average for the stock forecasts to be realized with a an average price target met ratio 5

Which analyst has the current highest performing score on ABCL (AbCellera Biologics) with a proven track record?

DO KIM

Which analyst has the current lower performing score on ABCL (AbCellera Biologics) with a proven track record?

GARY NACHMAN

Which analyst has the most public recommendations on ABCL (AbCellera Biologics)?

Do Kim works at PIPER SANDLER and has 53 price targets and 36 ratings on ABCL

Which analyst is the currently most bullish on ABCL (AbCellera Biologics)?

Tiago Fauth with highest potential upside - $28.92

Which analyst is the currently most reserved on ABCL (AbCellera Biologics)?

Puneet Souda with lowest potential downside - $12.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart